Today on Pharmaceutical Processing
ASLS wins Frost & Sullivan bioprinting award
WIPOTEC-OCS to tout product line at WestPack
Regulatory See More >
Drug deactivation system helps N.J. pharmacies comply with new anti-overdose law
Verde Environmental Technologies announced that it launched four new retail products with its Deterra system in compliance with New Jersey’s “Charlie’s Law” that requires every pharmacy practice site in the state to provide effective options for consumers to dispose of unused, unwanted or expired medications. The law requires pharmacies to carry effective drug disposal methods…
Facility See More >
The Rapid Rise of Modular Construction—Are Standardized Facilities Next?
In recent years, the discussion for flexible facility needs became widespread. The motivations for such flexible facility needs are manifold, for example, the requirement to rapidly deploy additional manufacturing capacities or scalability without interrupting existing processes. In addition, the transformation of the treatment or patient base to more personalized medicines necessitates the need to rethink…
Supply Chain See More >
First FDA-approved Vaccine for the Prevention of Dengue Disease in Endemic Regions
The U.S. Food and Drug Administration have announced the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 and 4) in people ages 9 through 16 who have laboratory-confirmed previous dengue infection and who live in endemic areas. Dengue is endemic in…
Recalls See More >
Torrent Pharmaceuticals Issues Voluntary Nationwide Recall of Losartan Potassium Tablets
Torrent Pharmaceuticals Limited is voluntarily recalling two lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. The impurity detected in the API is N-nitrosodiethylamine (NDEA), which is a substance that occurs…
